Sanara Medtech Inc (OQ:SMTI)

Mar 25, 2024 04:05 pm ET
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results
Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve...
Mar 13, 2024 09:15 am ET
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Dates
Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in...
Feb 22, 2024 09:15 am ET
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023
Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve...
Jan 03, 2024 09:15 am ET
Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen Peptides
Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), announced today that is has signed an exclusive license agreement with Tufts University (“Tufts”) to develop and...
Nov 30, 2023 09:15 am ET
Sanara MedTech Inc. Announces the Publication of a 5,335 Patient Study Demonstrating a Significant Reduction in Surgical Site Infections When Activated Collagen (CellerateRX® Surgical Powder) Was Used
Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve...
Nov 13, 2023 04:05 pm ET
Sanara MedTech Inc. Announces Third Quarter 2023 Results
Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve...
Oct 30, 2023 09:15 am ET
Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates
Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve...
Oct 10, 2023 09:15 am ET
Sanara MedTech Announces First Sale of ALLOCYTE® Plus Advanced Viable Bone Matrix and Provides Other Product Updates
Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in...
Sep 12, 2023 09:15 am ET
Sanara MedTech to Participate in Two Upcoming Conferences
Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in...
Aug 14, 2023 04:05 pm ET
Sanara MedTech Inc. Announces Second Quarter 2023 Results
Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve...
Aug 02, 2023 09:15 am ET
Sanara MedTech Inc. Announces the Acquisition of Certain Assets Related to its Collagen Products Business
Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve...
Aug 01, 2023 04:05 pm ET
Sanara MedTech Inc. Announces Second Quarter Earnings Release and Conference Call Dates
Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve...
May 15, 2023 04:15 pm ET
Sanara MedTech Inc. Announces First Quarter 2023 Results
Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve...
May 03, 2023 09:15 am ET
Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates
Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in...
Apr 04, 2023 09:15 am ET
Sanara MedTech Inc. Announces 510(k) Clearance for BIASURGE™ Advanced Surgical Solution
Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve...
Mar 20, 2023 04:15 pm ET
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2022 Results
Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve...
Mar 06, 2023 09:15 am ET
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2022 Earnings Release and Conference Call Dates
Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve...
Feb 22, 2023 09:15 am ET
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2022
Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve...
Nov 21, 2022 09:15 am ET
Sanara MedTech to Participate in Two Upcoming Healthcare Conferences
Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today that Zach Fleming, the Company’s...
Nov 14, 2022 04:15 pm ET
Sanara MedTech Inc. Announces Third Quarter 2022 Results
Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes,...
Nov 03, 2022 09:15 am ET
Sanara MedTech and InfuSystem Announce Wound Therapy Partnership
Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI) and InfuSystem Holdings, Inc. (“InfuSystem”) (NYSE American: INFU) announced today the establishment of a partnership, SI Wound Care, LLC (“SI Wound Care”), focused...
Nov 03, 2022 06:30 am ET
InfuSystem and Sanara MedTech Announce Wound Therapy Partnership
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”) and Sanara MedTech Inc. (NASDAQ: SMTI) (“Sanara”) announced today the establishment of a partnership, SI Wound Care, LLC (“SI Wound Care”), focused on delivering a complete wound care solution targeted at improving patient outcomes, lowering the cost of care, and increasing patient and provider satisfaction. The partnership is expected to enable InfuSystem to offer innovative products including Cork Medical LLC’s (“Cork”) negative pressure wound therapy (“NPWT”) devices and supplies and Sanara’s advanced wound care
Nov 01, 2022 09:15 am ET
Sanara MedTech Inc. Announces Third Quarter 2022 Earnings Release and Conference Call Dates
Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes,...
Sep 06, 2022 09:15 am ET
Sanara MedTech to Present at the Virtual MicroCap Leadership Summit
Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today that it has been selected to...
Aug 15, 2022 04:15 pm ET
Sanara MedTech Inc. Announces Second Quarter 2022 Results
Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today its strategic, operational and...
Aug 03, 2022 09:15 am ET
Sanara MedTech Inc. Announces Second Quarter 2022 Earnings Release and Conference Call Dates
Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today details for the release of its...
Jul 05, 2022 09:15 am ET
Sanara MedTech Inc. Announces Closing of Scendia Biologics, LLC Acquisition
Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes,...
May 16, 2022 04:30 pm ET
Sanara MedTech Inc. Announces First Quarter 2022 Results
Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today its strategic, operational and...
May 02, 2022 09:15 am ET
Sanara MedTech Inc. Announces First Quarter 2022 Earnings Release and Conference Call Dates
Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today details for the release of its...
Apr 04, 2022 06:45 pm ET
Sanara MedTech Inc. Announces Closing of Merger to Acquire Precision Healing Inc.
Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today that it has closed the...
Apr 04, 2022 06:30 am ET
Sanara MedTech Inc. Announces Entry into Merger Agreement to Acquire Precision Healing Inc.
Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes,...
Mar 30, 2022 04:15 pm ET
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2021 Results
Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes,...
Mar 14, 2022 09:15 am ET
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2021 Earnings Release and Conference Call Dates
Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes,...
Feb 22, 2022 09:15 am ET
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2021
Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today certain unaudited preliminary results for the...
Dec 28, 2021 09:15 am ET
Sanara MedTech Inc. Announces the Appointment of Zachary B. Fleming as Chief Executive Officer
Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today that Zachary (“Zach”) B. Fleming has been appointed...
Dec 22, 2021 04:05 pm ET
Sanara MedTech Inc. Announces the Retirement of J. Michael Carmena and Appointment of Eric Tanzberger to its Board of Directors
Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today that J. Michael (“Mike”) Carmena will step down...
Dec 15, 2021 09:15 am ET
Sanara MedTech Inc. Announces the Appointment of Roszell Mack III to its Board of Directors
Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today that Roszell Mack III has been appointed to the...
Nov 12, 2021 04:15 pm ET
Sanara MedTech Inc. Announces Third Quarter 2021 Results and Business Update
FORT WORTH, TX / ACCESSWIRE / November 12, 2021 / Sanara MedTech Inc.
Nov 09, 2021 09:15 am ET
Oct 28, 2021 09:15 am ET
Sanara MedTech Inc. Announces Third Quarter 2021 Earnings Release and Conference Call Dates
FORT WORTH, TX / ACCESSWIRE / October 28, 2021 / Sanara MedTech Inc.
Sep 22, 2021 09:15 am ET
Sanara MedTech to Present at the 2021 Cantor Virtual Global Healthcare Conference
FORT WORTH, TX / ACCESSWIRE / September 22, 2021 / Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (NASDAQ:SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today that the Company is scheduled to present virtually at the 2021 Cantor Virtual Global Healthcare Conference. Sanara's presentation will be given on Wednesday, September 29, 2021 at 9:20 a.m. ET.
Aug 26, 2021 09:15 am ET
Sanara MedTech to Present at the Virtual MicroCap Leadership Summit
FORT WORTH, TX / ACCESSWIRE / August 26, 2021 / Sanara MedTech Inc.
Aug 16, 2021 04:15 pm ET
Sanara MedTech Inc. Announces Second Quarter 2021 Results and Business Update
FORT WORTH, TX / ACCESSWIRE / August 16, 2021 / Sanara MedTech Inc .
Aug 02, 2021 09:15 am ET
Sanara MedTech Inc. Announces Second Quarter 2021 Earnings Release and Conference Call Dates
FORT WORTH, TX / ACCESSWIRE / August 2, 2021 / Sanara MedTech Inc.
Jul 19, 2021 09:15 am ET
Sanara MedTech Inc. Announces the Purchase of Certain Assets from Rochal Industries, LLC
FORT WORTH, TX / ACCESSWIRE / July 19, 2021 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (NASDAQ:SMTI), a provider of surgical and chronic wound care products dedicated to improving patient outcomes, announced today the acquisition of certain assets of Rochal Industries, LLC ("Rochal").
May 17, 2021 09:15 am ET
Sanara MedTech Inc. Announces First Quarter 2021 Results and Business Update
FORT WORTH, TX / ACCESSWIRE / May 17, 2021 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (NASDAQ:SMTI), a provider of surgical and chronic wound care products dedicated to improving patient outcomes, announced today its strategic, operational and financial results for the quarter ended March 31, 2021.
Mar 31, 2021 09:15 am ET
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2020 Results
FORT WORTH, TX / ACCESSWIRE / March 31, 2021 / Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (NASDAQ:SMTI), a provider of surgical and chronic wound care products dedicated to improving patient outcomes, announced today its strategic, operational and financial results for the quarter and full year ended December 31, 2020.
Feb 12, 2021 09:20 am ET
Sanara MedTech Inc. Announces Pricing of Public Offering
FORT WORTH, TX / ACCESSWIRE / February 12, 2021 / Sanara MedTech Inc.
Feb 11, 2021 04:01 pm ET
Sanara MedTech Inc. Announces Proposed Public Offering of Common Stock
FORT WORTH, TX / ACCESSWIRE / February 11, 2021 / Sanara MedTech Inc.
Jan 25, 2021 04:10 pm ET
Sanara MedTech Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2020
FORT WORTH, TX / ACCESSWIRE / January 25, 2021 / Sanara MedTech Inc.
Dec 23, 2020 09:15 am ET
Sanara MedTech Inc. Announces the Appointment of Sara Ortwein to its Board of Directors
FORT WORTH, TX / ACCESSWIRE / December 23, 2020 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara" or the "Company") (NASDAQ:SMTI), a provider of wound and skin care products dedicated to improving patient outcomes, announced today that Sara Ortwein has been appointed to the Company's Board of Directors (the "Board"), effective December 18, 2020.
Nov 13, 2020 04:45 pm ET
Sanara MedTech Inc. Announces Third Quarter 2020 Results
FORT WORTH, TX / ACCESSWIRE / November 13, 2020 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara" or the "Company") (NASDAQ:SMTI), a provider of wound and skin care products dedicated to improving patient outcomes, announced today its strategic, operational and financial results for the quarter and nine months ended September 30, 2020.
Nov 13, 2020 09:15 am ET
Sanara MedTech Inc. Announces that it has Closed an Exclusive Affiliation with Precision Healing Inc.
FORT WORTH, TX / ACCESSWIRE / November 13, 2020 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara" or the "Company") (NASDAQ:SMTI), a provider of wound and skincare products dedicated to improving patient outcomes, announced today that through its subsidiary United Wound and Skin Solutions, LLC ("UWSS"), it has closed an exclusive affiliation with Precision Healing, Inc. to commercialize its proprietary diagnostic systems to improve overall outcomes in the chronic wound care population.
Nov 05, 2020 09:15 am ET
Sanara MedTech Announces the Launch of BIAKŌS(TM) Antimicrobial Wound Gel As Well as Recent Viral Testing Results for BIAKŌS(TM) Skin and Wound Cleanser
FORT WORTH, TX / ACCESSWIRE / November 5, 2020 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara" or the "Company") (NASDAQ:SMTI), a provider of wound and skin care products dedicated to improving patient outcomes, announced the launch of BIAKŌS™ Antimicrobial Wound Gel as well as recent viral testing results for BIAKŌS™ Skin and Wound Cleanser.
Oct 29, 2020 09:15 am ET
Sanara MedTech Inc. Announces Uplisting to The Nasdaq Capital Market
FORT WORTH, TX / ACCESSWIRE / October 29, 2020 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara" or the "Company") (OTCQB:SMTI), a provider of wound and skin care products and virtual consult services dedicated to improving patient outcomes, announced today that it has received approval to list its common stock on The Nasdaq Capital Market ("Nasdaq"). Sanara's common stock is expected to begin trading on The Nasdaq Capital Market effective at the opening of trading hours on November 2, 2020 under its curren
Oct 15, 2020 09:15 am ET
Sanara MedTech Inc. Announces the Appointment of Bob DeSutter to Its Board of Directors
FORT WORTH, TX / ACCESSWIRE / October 15, 2020 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara" or the "Company") (OTCQB:SMTI), a provider of wound and skin care products and virtual consult services dedicated to improving patient outcomes, announced today that Bob DeSutter has been appointed to the Company's Board of Directors (the "Board"), effective October 12, 2020.
Oct 06, 2020 09:15 am ET
Sanara MedTech Inc. Announces that it has Closed on an Exclusive Affiliation with MGroup Integrated Physician Services, P.A.
FORT WORTH, TX / ACCESSWIRE / October 6, 2020 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara" or the "Company") (OTCQB:SMTI), a provider of wound and skin care products and solutions dedicated to improving patient outcomes, announced that it has closed on an exclusive affiliation with MGroup Integrated Physician Services, P.A. ("MGroup"). Pursuant to this arrangement, Sanara, through its subsidiary United Wound and Skin Solutions LLC ("UWSS"), has agreed to provide certain management services to MGroup and
Aug 17, 2020 09:15 am ET
Sanara MedTech Inc. Announces an Expansion into Virtual Wound and Skin Care
FORT WORTH, TX / ACCESSWIRE / August 17, 2020 / Sanara MedTech Inc.
Aug 13, 2020 09:15 am ET
Sanara MedTech Inc. Announces Second Quarter 2020 Results
FORT WORTH, TX / ACCESSWIRE / August 13, 2020 / Sanara MedTech Inc.
Jul 08, 2020 09:15 am ET
Jun 03, 2020 09:25 am ET
Sanara MedTech Inc. Announces Recent Testing Results Showing That BIAKŌS(TM) Antimicrobial Skin and Wound Cleanser Is Effective Against SARS-CoV-2, MRSA, and VRE
FORT WORTH, TX / ACCESSWIRE / June 3, 2020 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara" or the "Company") (OTCQB:SMTI), a provider of wound and skin care products dedicated to improving patient outcomes, announced today the results of testing performed with the Company's BIAKŌS™ Antimicrobial Skin and Wound Cleanser against Severe Acute Respiratory Syndrome Coronavirus 2 ("SARS-CoV-2"), the virus that causes Coronavirus Disease 2019 ("COVID-19"). This is in addition to BIAKŌS's™ prev
May 11, 2020 09:00 am ET
Sanara MedTech Inc. Announces the Execution of a New License Agreement with Rochal Industries, LLC
FORT WORTH, TX / ACCESSWIRE / May 11, 2020 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara" or the "Company") (OTCQB:SMTI), a provider of surgical and chronic wound care products dedicated to improving patient outcomes, announced today the execution of a new license agreement with Rochal Industries, LLC, for an autolytic debrider wound dressing currently under development.
Apr 17, 2020 09:00 am ET
Sanara MedTech Inc. Announces an Update on the Execution of its Strategy
FORT WORTH, TX / ACCESSWIRE / April 17, 2020 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara" or the "Company") (OTCQB:SMTI), a provider of surgical and chronic wound care products dedicated to improving patient outcomes, announced today an update on the execution of the Company's strategy.
Mar 26, 2020 06:50 pm ET
Sanara MedTech Inc. Announces 2019 Results
FORT WORTH, TX / ACCESSWIRE / March 26, 2020 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara" or the "Company") (OTCQB:SMTI), a provider of surgical and chronic wound care products dedicated to improving patient outcomes, announced today its strategic, operational and financial results for the quarter and full-year ended December 31, 2019.
Feb 10, 2020 09:00 am ET
Sanara MedTech Inc. Announces That The Catalyst Group Has Converted Its 30-Month Promissory Note and Series F Convertible Preferred Stock Into Common Equity
FORT WORTH, TX / ACCESSWIRE / February 10, 2020 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara" or the "Company") (OTCQB:SMTI), a provider of surgical and chronic wound care products dedicated to improving patient outcomes, announced today that on February 7, 2020 The Catalyst Group, Inc. ("Catalyst") converted into Common Stock Catalyst's entire holdings of the Company's 30-month $1,500,000 convertible promissory note and Series F Convertible Preferred Stock.
Jan 28, 2020 09:00 am ET
Sanara MedTech Inc. Announces the Appointment of Zach Fleming and Shawn Bowman as Co-Chief Operating Officers
FORT WORTH, TX / ACCESSWIRE / January 28, 2020 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara" or the "Company") (OTCQB:SMTI), a provider of surgical and chronic wound care products dedicated to improving patient outcomes, announced today that the Board of Directors has approved the appointment of Zach Fleming and Shawn Bowman as Co-Chief Operating Officers of the Company. Mr. Fleming currently serves as the President of the Company's Surgical Division, and Mr. Bowman currently serves as the President of the Company's
Jan 13, 2020 09:00 am ET
Sanara MedTech Inc. Announces That It Has Agreed to Retain Donald Stelly on a Long-Term Engagement
FORT WORTH, TX / ACCESSWIRE / January 13, 2020 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara" or the "Company") (OTCQB:SMTI), a provider of surgical and chronic wound care products dedicated to improving patient outcomes, announced today that it has agreed to engage Donald Stelly for two years to provide services to Sanara in support of the expansion of its business in wound and skin care. The contract is anticipated to be finalized in the next few weeks.
Nov 14, 2019 09:30 am ET
Sanara MedTech Inc. Announces Third Quarter 2019 Results
FORT WORTH, TX / ACCESSWIRE / November 14, 2019 / Sanara MedTech Inc.
Oct 30, 2019 08:00 am ET
Sanara MedTech Inc. Announces Update to Strategic Plans
FORT WORTH, TX / ACCESSWIRE / October 30, 2019 / Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara" or "the Company") (OTCQB:SMTI), a provider of surgical and chronic wound care products dedicated to improving patient outcomes, announced an update today to its strategic plans.
Oct 16, 2019 09:00 am ET
Sanara MedTech Inc. Announces Closing of $10,000,000 Private Placement of Common Stock
FORT WORTH, TX / ACCESSWIRE / October 16, 2019 / Sanara MedTech Inc. (OTCQB:SMTI). Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara"), a provider of surgical and chronic wound care products dedicated to improving patient outcomes, announced today that it has closed a private placement offering of 1,204,820 shares of its common stock at a price of $8.30 per share. All shares are being sold by Sanara as newly issued shares. The purchasers in the offering consist of related party entities to three members of Sanara's Board of Directors. The transaction was a
Oct 07, 2019 01:25 pm ET
Sanara MedTech Inc. Announces a Second Exclusive Licensing Agreement with Rochal Industries for Two New Impactful Products
FORT WORTH, TX / ACCESSWIRE / October 7, 2019 / Sanara MedTech Inc. (OTCQB:SMTI).
Aug 29, 2019 12:22 pm ET
Sanara MedTech Inc. Announces the Election of Dr. Kenneth Thorpe and Ms. Ann Beal Salamone to its Board of Directors
Ann Beal Salamone, M.S., who has focused on wound care since 1986, is a member of the National Academy of Engineering and The Academy of Medicine, Engineering & Science of Texas (TAMEST). She has developed products for electronics, water purification, personal care and healthcare and has invested in and served on the boards for several entrepreneurial companies as well as co-founded six companies. She is a co-founder of Rochal Industries LLC based in San Antonio, Texas, and one of the principal inventors of Rochal’s liquid bandages,
Jun 25, 2019 08:30 am ET
Sanara MedTech Inc. Announces Expanded Line of Credit, Launch of BIAKOS(TM) Antimicrobial Skin & Wound Cleanser and Approval of Stock Purchase Program
FORT WORTH, TX / ACCESSWIRE / June 25, 2019 / Sanara MedTech Inc. (OTCQB: SMTI) Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara" or the "Company"), a provider of surgical and chronic wound care products dedicated to improving patient outcomes, today announced (1) an expanded line of credit with Cadence Bank, (2) the launch of BIAKŌS™ Antimicrobial Skin & Wound Cleanser, and (3) the approval of a stock purchase program.
Jun 07, 2019 08:00 am ET
Sanara MedTech Inc. Announces FINRA Approval for New Trading Symbol - (SMTI)
FORT WORTH, TX / ACCESSWIRE / June 7, 2019 / Sanara MedTech Inc. (OTCQB: SMTI) announced today that the Financial Industry Regulatory Authority (FINRA) has approved the Company's request to change its stock ticker symbol from WNDMD to SMTI effective at the start of trading on June 7, 2019. The stock will be traded under a the CUSIP number 79957L100.

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.